Human Molecular Genetics, 2000, Vol. 9, No. 12 1771-1778
© 2000 Oxford University Press
Cellular and viral splicing factors can modify the splicing pattern of CFTR transcripts carrying splicing mutations
Department of Genetics, Life Sciences Institute, The Hebrew University, Jerusalem 91904, Israel and 1Gesher-Israel Advanced Biotecs, Beit Neqofa 90830, Israel
Variable levels of aberrantly spliced cystic fibrosis transmembrane conductance regulator (CFTR ) transcripts were suggested to correlate with variable cystic fibrosis (CF) severity. We studied the effect of the cellular splicing factors, hnRNP A1 and ASF/SF2, and their adenoviral analogues, E4-ORF6 and E4-ORF3, that promote exon skipping and/or exon inclusion, on the splicing pattern of the CFTR mutation 3849+10kb C
T and the 5T allele. These mutations can lead to cryptic exon inclusion and exon skipping, respectively. Overexpression of the cellular factors promoted exon skipping of pre-mRNA transcribed from minigenes carrying the mutation (p5T or p3849M). This led to a substantial decrease in the level of correctly spliced mRNA transcribed from p5T and generated correctly spliced mRNA transcribed from p3849M that was not found without overexpression of the factors. The viral factor, E4-ORF3, promoted exon inclusion and led to a substantial increase of the correctly spliced mRNA transcribed from the p5T. The factor, E4-ORF6, activated exon skipping and generated correctly spliced mRNA transcribed from p3849M. Thus, overexpression of alternative splicing factors can modulate the splicing pattern of CFTR alleles carrying splicing mutations. These results are important for understanding the mechanism underlying phenotypic variability in CF and other genetic diseases.
+ These authors contributed equally to this work
§ To whom correspondence should be addressed. Tel: +972 2 6585689; Fax: +972 2 6586975; Email kerem@leonardo.ls.huji.ac.il
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  E. Buratti, C. Stuani, G. De Prato, and F. E. Baralle SR protein-mediated inhibition of CFTR exon 9 inclusion: molecular characterization of the intronic splicing silencer Nucleic Acids Res., July 26, 2007; 35(13): 4359 - 4368. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Radpour, H. Gourabi, M. A. S. Gilani, and A. V. Dizaj Molecular Study of (TG)m(T)n Polymorphisms in Iranian Males With Congenital Bilateral Absence of the Vas Deferens J Androl, July 1, 2007; 28(4): 541 - 547. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. M. Ziedalski, P. N. Kao, N. R. Henig, S. S. Jacobs, and S. J. Ruoss Prospective analysis of cystic fibrosis transmembrane regulator mutations in adults with bronchiectasis or pulmonary nontuberculous mycobacterial infection. Chest, October 1, 2006; 130(4): 995 - 1002. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Buratti, A. Brindisi, M. Giombi, S. Tisminetzky, Y. M. Ayala, and F. E. Baralle TDP-43 Binds Heterogeneous Nuclear Ribonucleoprotein A/B through Its C-terminal Tail: AN IMPORTANT REGION FOR THE INHIBITION OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR EXON 9 SPLICING J. Biol. Chem., November 11, 2005; 280(45): 37572 - 37584. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Gabut, M. Mine, C. Marsac, M. Brivet, J. Tazi, and J. Soret The SR Protein SC35 Is Responsible for Aberrant Splicing of the E1{alpha} Pyruvate Dehydrogenase mRNA in a Case of Mental Retardation with Lactic Acidosis Mol. Cell. Biol., April 15, 2005; 25(8): 3286 - 3294. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. E. Willoughby, L. L. Y. Chan, S. Herd, G. Billingsley, N. Noordeh, A. V. Levin, Y. Buys, G. Trope, M. Sarfarazi, and E. Heon Defining the Pathogenicity of Optineurin in Juvenile Open-Angle Glaucoma Invest. Ophthalmol. Vis. Sci., September 1, 2004; 45(9): 3122 - 3130. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. A. Slaugenhaupt, J. Mull, M. Leyne, M. P. Cuajungco, S. P. Gill, M. M. Hims, F. Quintero, F. B. Axelrod, and J. F. Gusella Rescue of a human mRNA splicing defect by the plant cytokinin kinetin Hum. Mol. Genet., February 15, 2004; 13(4): 429 - 436. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Aznarez, E. M. Chan, J. Zielenski, B. J. Blencowe, and L.-C. Tsui Characterization of disease-associated mutations affecting an exonic splicing enhancer and two cryptic splice sites in exon 13 of the cystic fibrosis transmembrane conductance regulator gene Hum. Mol. Genet., August 15, 2003; 12(16): 2031 - 2040. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Pagani, E. Buratti, C. Stuani, and F. E. Baralle Missense, Nonsense, and Neutral Mutations Define Juxtaposed Regulatory Elements of Splicing in Cystic Fibrosis Transmembrane Regulator Exon 9 J. Biol. Chem., July 11, 2003; 278(29): 26580 - 26588. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. A. Faustino and T. A. Cooper Pre-mRNA splicing and human disease Genes & Dev., February 15, 2003; 17(4): 419 - 437. [Full Text] [PDF]
|
|
|
|
|
|
F. Pagani, C. Stuani, E. Zuccato, A. R. Kornblihtt, and F. E. Baralle Promoter Architecture Modulates CFTR Exon 9 Skipping J. Biol. Chem., January 10, 2003; 278(3): 1511 - 1517. [Abstract] [Full Text] [PDF]
|
|